Authors:
FLECKENSTEIN AE
KOKOSHKA JM
VAUGHAN RA
METZGER RR
GIBB JW
HANSON GR
Citation: Ae. Fleckenstein et al., SELECTIVE AND REVERSIBLE EFFECTS OF METHAMPHETAMINE ON STRIATAL DOPAMINE TRANSPORTERS, The FASEB journal, 12(4), 1998, pp. 928-928
Authors:
FLECKENSTEIN AE
KOKOSHKA JM
GIBB JW
HANSON GR
Citation: Ae. Fleckenstein et al., CHARACTERIZATION OF THE RAPID AND REVERSIBLE EFFECTS OF METHAMPHETAMINE ON DOPAMINE TRANSPORTERS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 35195-35195
Authors:
METZGER RR
HANSON GR
GIBB JW
FLECKENSTEIN AE
Citation: Rr. Metzger et al., 3,4-METHYLENEDIOXYMETHAMPHETAMINE-INDUCED ACUTE CHANGES IN DOPAMINE TRANSPORTER FUNCTION, European journal of pharmacology, 349(2-3), 1998, pp. 205-210
Authors:
KOKOSHKA JM
METZGER RR
WILKINS DG
GIBB JW
HANSON GR
FLECKENSTEIN AE
Citation: Jm. Kokoshka et al., METHAMPHETAMINE TREATMENT RAPIDLY INHIBITS SEROTONIN, BUT NOT GLUTAMATE, TRANSPORTERS IN RAT-BRAIN, Brain research, 799(1), 1998, pp. 78-83
Authors:
HANSON GR
BUSH LG
TAYLOR VL
GIBB JW
DAVIS K
SCHMIDT CJ
Citation: Gr. Hanson et al., COMPARISON OF NEUROTENSIN RESPONSES TO MDL-100,907, A SELECTIVE 5HT(2A) ANTAGONIST, WITH CLOZAPINE AND HALOPERIDOL, Brain research bulletin, 42(3), 1997, pp. 211-219
Authors:
GYGI MP
FLECKENSTEIN AE
GIBB JW
HANSON GR
Citation: Mp. Gygi et al., ROLE OF ENDOGENOUS DOPAMINE IN THE NEUROCHEMICAL DEFICITS INDUCED BY METHCATHINONE, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1350-1355
Citation: Jw. Gibb et al., EXACERBATION OF METHAMPHETAMINE-INDUCED NEUROCHEMICAL DEFICITS BY MELATONIN, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 630-635
Authors:
FLECKENSTEIN AE
WILKINS DG
GIBB JW
HANSON GR
Citation: Ae. Fleckenstein et al., INTERACTION BETWEEN HYPERTHERMIA AND OXYGEN RADICAL FORMATION IN THE 5-HYDROXYTRYPTAMINERGIC RESPONSE TO A SINGLE METHAMPHETAMINE ADMINISTRATION, The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 281-285
Citation: Ae. Fleckenstein et al., RAPID AND REVERSIBLE EFFECTS OF METHAMPHETAMINE ON DOPAMINE TRANSPORTERS, The Journal of pharmacology and experimental therapeutics, 282(2), 1997, pp. 834-838
Authors:
FLECKENSTEIN AE
METZGER RR
BEYELER ML
GIBB JW
HANSON GR
Citation: Ae. Fleckenstein et al., OXYGEN RADICALS DIMINISH DOPAMINE TRANSPORTER FUNCTION IN RAT STRIATUM, European journal of pharmacology, 334(1), 1997, pp. 111-114
Authors:
FLECKENSTEIN AE
BEYELER ML
JACKSON JC
WILKINS DG
GIBB JW
HANSON GR
Citation: Ae. Fleckenstein et al., METHAMPHETAMINE-INDUCED DECREASE IN TRYPTOPHAN-HYDROXYLASE ACTIVITY -ROLE OF 5-HYDROXYTRYPTAMINERGIC TRANSPORTERS, European journal of pharmacology, 324(2-3), 1997, pp. 179-186
Authors:
FLECKENSTEIN AE
METZGER RR
GIBB JW
HANSON GR
Citation: Ae. Fleckenstein et al., A RAPID AND REVERSIBLE CHANGE IN DOPAMINE TRANSPORTERS INDUCED BY METHAMPHETAMINE, European journal of pharmacology, 323(2-3), 1997, pp. 9-10
Citation: Jd. Wagstaff et al., ROLE OF DOPAMINE D-1-RECEPTORS AND NMDA RECEPTORS IN REGULATING NEUROTENSIN RELEASE IN THE STRIATUM AND NUCLEUS-ACCUMBENS, Brain research, 748(1-2), 1997, pp. 241-244
Citation: Jd. Wagstaff et al., MICRODIALYSIS ASSESSMENT OF METHAMPHETAMINE-INDUCED CHANGES IN EXTRACELLULAR NEUROTENSIN IN THE STRIATUM AND NUCLEUS-ACCUMBENS, The Journal of pharmacology and experimental therapeutics, 278(2), 1996, pp. 547-554
Citation: Mp. Gygi et al., METHCATHINONE - AN INITIAL STUDY OF ITS EFFECTS ON MONOAMINERGIC SYSTEMS, The Journal of pharmacology and experimental therapeutics, 276(3), 1996, pp. 1066-1072
Citation: Jd. Wagstaff et al., DOPAMINE D-2-RECEPTORS REGULATE NEUROTENSIN RELEASE FROM NUCLEUS-ACCUMBENS AND STRIATUM AS MEASURED BY IN-VIVO MICRODIALYSIS, Brain research, 721(1-2), 1996, pp. 196-203
Citation: Sz. Che et al., BODY-TEMPERATURE EFFECT ON METHYLENEDIOXYMETHAMPHETAMINE-INDUCED ACUTE DECREASE IN TRYPTOPHAN-HYDROXYLASE ACTIVITY, European journal of pharmacology. Environmental toxicology and pharmacology section, 293(4), 1995, pp. 447-453
Authors:
HANSON GR
SINGH N
MERCHANT K
JOHNSON M
GIBB JW
Citation: Gr. Hanson et al., THE ROLE OF NMDA RECEPTOR SYSTEMS IN NEUROPEPTIDE RESPONSES TO STIMULANTS OF ABUSE, Drug and alcohol dependence, 37(2), 1995, pp. 107-110
Citation: Gr. Hanson et al., RESPONSE OF EXTRAPYRAMIDAL AND LIMBIC NEUROTENSIN SYSTEMS TO PHENCYCLIDINE TREATMENT, European journal of pharmacology, 278(2), 1995, pp. 167-173
Authors:
JOHNSON M
HANSON GR
GIBB JW
ADAIR J
FILLOUX F
Citation: M. Johnson et al., EFFECT OF NEONATAL HYPOXIA-ISCHEMIA ON NIGRO-STRIATAL DOPAMINE-RECEPTORS AND ON STRIATAL NEUROPEPTIDE-Y, DYNORPHIN-A AND SUBSTANCE-P CONCENTRATIONS IN RATS, Developmental brain research, 83(1), 1994, pp. 109-118
Authors:
JOHNSON M
SONSALLA PK
LETTER AA
HANSON GR
GIBB JW
Citation: M. Johnson et al., ROLE OF THE 5-HT2 RECEPTOR IN THE METHAMPHETAMINE-INDUCED NEUROCHEMICAL ALTERATIONS, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 97-103
Citation: Sp. Gygi et al., DIFFERENTIAL-EFFECTS OF ANTIPSYCHOTIC AND PSYCHOTOMIMETIC DRUGS ON NEUROTENSIN SYSTEMS OF DISCRETE EXTRAPYRAMIDAL AND LIMBIC REGIONS, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 192-197
Authors:
MIDGLEY LP
WAGSTAFF JD
SINGH NA
BUSH LG
GIBB JW
HANSON GR
Citation: Lp. Midgley et al., DYNAMIC DOPAMINERGIC REGULATION OF NEUROPEPTIDE-Y SYSTEMS IN DISCRETESTRIATAL AND ACCUMBENS REGIONS, European journal of pharmacology, 251(2-3), 1994, pp. 191-199